Uncategorized

Using a specific type of MRI, researchers observed brain changes in people up to six months after they recovered from COVID-19. The work will be presented at the annual conference of the Radiological Society of North America next week. According to the Centers for Disease Control and Prevention, around one in every five individuals will experience long-term consequences from COVID-19. Long-term COVID causes neurological symptoms such as trouble thinking or focusing, headache, sleep issues, lightheadedness, pins-and-needles feeling, change in smell or taste, and depression or anxiety. COVID-19, on the other hand, has been linked to abnormalities in the heart, lungs, and other organs in asymptomatic people, according to research.

As more people become infected with and recover from COVID-19, research concentrating on the disease’s long-term implications has begun to surface. The researchers employed susceptibility-weighted imaging to examine the effects of COVID-19 on the brain in this investigation. Magnetic susceptibility is the degree to which particular materials, such as blood, iron, and calcium, will become magnetised in the presence of a magnetic field. This skill facilitates in the detection and monitoring of a variety of neurologic disorders such as microbleeds, vascular malformations, brain tumours, and stroke.

“Group-level studies have not previously focused on COVID-19 changes in magnetic susceptibility of the brain despite several case reports signalling such abnormalities,” said study co-author Sapna S. Mishra, a PhD candidate at the Indian Institute of Technology in Delhi. “Our study highlights this new aspect of the neurological effects of COVID-19 and reports significant abnormalities in COVID survivors.”

The susceptibility-weighted MRI data of 46 COVID-recovered patients and 30 healthy controls were examined by the researchers. Imaging was performed six months after recovery. The most often reported symptoms among individuals with extended COVID were weariness, difficulty sleeping, loss of focus, and memory problems.

“Changes in susceptibility values of brain regions may be indicative of local compositional changes,” Mishra said. “Susceptibilities may reflect the presence of abnormal quantities of paramagnetic compounds, whereas lower susceptibility could be caused by abnormalities like calcification or lack of paramagnetic molecules containing iron.”

When MRI data were compared to healthy controls, patients who recovered from COVID-19 had considerably greater susceptibility levels in the frontal lobe and brain stem. The frontal lobe clusters found mostly exhibit variations in white matter.

“These brain regions are linked with fatigue, insomnia, anxiety, depression, headaches and cognitive problems,” Mishra said.

The frontal lobe clusters were made up of portions of the left orbital-inferior frontal gyrus (a key region for language comprehension and production) and right orbital-inferior frontal gyrus (associated with various cognitive functions such as attention, motor inhibition, and imagery, as well as social cognitive processes) and the adjacent white matter areas.

The researchers also discovered a substantial difference in the brain stem’s right ventral diencephalon area. This area is involved in several important biological activities, such as coordinating hormone release with the endocrine system, sending sensory and motor impulses to the cerebral cortex, and regulating circadian cycles (the sleep-wake cycle).

“This study points to serious long-term complications that may be caused by the coronavirus, even months after recovery from the infection,” Mishra said. “The present findings are from the small temporal window. However, the longitudinal time points across a couple of years will elucidate if there exists any permanent change.”

The researchers are now doing a long-term investigation on the same patient group to see if these brain anomalies remain over time.

Aortic valve stenosis occurs when the aortic valve narrows, limiting blood flow from the heart to the artery and then to the rest of the body. It can cause cardiac failure in extreme circumstances. Identifying the illness in distant places can be challenging since it needs advanced technology and early stage diagnoses are difficult to get.

Researchers from the University of Kerala and the University of Nova Gorica in Slovenia published a method to discover valve failure using a complicated network analysis that is accurate, simple to use, and low-cost in the Journal of Applied Physics, published by AIP Publishing.

“Many rural health centers don’t have the necessary technology for analysing diseases like this,” said author MS Swapna, of the University of Nova Gorica and the University of Kerala, adding, “For our technique, we just need a stethoscope and a computer.”

The diagnostic technique is based on the noises made by the heart. While the mitral and tricuspid valves shut, the organ makes a “lub” noise, stops as ventricular relaxation occurs and blood flows in, and then makes a “dub” noise as the aortic and pulmonary valves close.

Swapna and her colleagues created a graph, or a complicated network of connected nodes, using heart sound data gathered over 10 minutes. The data was divided into portions, and each segment was represented on the graph by a node, or a single point. A line, or edge, was drawn between the two nodes if the sound in that piece of the data was comparable to another segment.

The network in a healthy heart exhibited two different groups of points, with many nodes remaining disconnected. A heart with aortic stenosis, on the other hand, has many more relationships and edges. “In the case of aortic stenosis, there is no separation between the lub and dub sound signals,” Swapna said.

The researchers examined the graphs using machine learning to identify individuals with and without illness, attaining a classification accuracy of 100%. Their approach evaluates the correlation of each point, making it more accurate than others, merely the intensity of the signal, and accomplishes so in less than 10 minutes. It might help with early-stage diagnosis.

So far, the procedure has only been evaluated with data and has not been tested in a clinical context. The writers are working on a mobile application that will be available worldwide. Their method might possibly be used to diagnose other diseases. “The proposed method can be extended to any type of heart sound signals, lung sound signals, or cough sound signals,” Swapna said.

A recent University of Arizona Health Sciences study discovered that persons over 45 with Type 2 diabetes who were treated with anti-hyperglycemic drugs had a higher risk of multiple sclerosis, particularly among women, but people under 45 had a lower risk.

“Our findings reinforce the need for a precision medicine approach to preventing MS in these vulnerable populations,” said lead researcher Kathleen Rodgers, PhD, associate director of translational neuroscience at the Center for Innovation in Brain Science. MS is an unexpected autoimmune neurological condition that affects the central nervous system and causes significant physical and cognitive impairment.

It is estimated that about 1 million individuals in the United States and more than 2.8 million globally have MS. There is emerging evidence associating metabolic problems and MS in persons with Type 2 diabetes via a similar cause of increased autoimmune. This calls into question the influence of anti-hyperglycemic therapies, such as insulin, used to treat Type 2 diabetes on the prevalence of MS.

“Previous research has shown a neuroprotective effect of anti-hyperglycemic medications in Alzheimer’s disease and other related dementias,” Dr. Rodgers said. “For MS, we wanted to further examine age and sex differences, particularly among men and women under 45 with Type 2 diabetes.”

They discovered that males over 45 had a little higher risk of MS, but women over 45 had a significantly higher incidence of MS following anti-hyperglycemic treatment. In addition to age differences, the risk analysis by medication class revealed that insulin exposure in individuals over the age of 45 was linked with a higher risk compared to other treatments.  Anti-hyperglycemic medication was found to be protective against the development of MS in patients under the age of 45. The study used a 151 million-person insurance claims database in the United States to identify more than 5 million people with Type 2 diabetes and either early-onset or late-onset MS.

To decipher the factors influencing MS risk in both populations, researchers split the data by age (patients diagnosed with Type 2 diabetes before or after the age of 45) and sex. The paper, “Age and sex differences on anti-hyperglycemic medication exposure and risk of newly diagnosed multiple sclerosis in propensity score-matched type 2 diabetics,” was published recently in the journal Heliyon.

Variable voltages have been discovered in the membranes of breast cancer cells, offering insight into how the cells multiply and spread. The research, which is being done collaboratively by Imperial College London and The Institute of Cancer Research, London, may increase our knowledge of how cancer cells “decide” whether to multiply and where to spread. As cells acquire cancer, they undergo a multitude of bioelectric alterations. The cell membrane, which surrounds cells, for example, becomes more positively charged than healthy cell membranes.

This new study, published in the journal Communications Biology, revealed that breast cancer cells behaved similarly to neurons and had higher membrane voltages than healthy cells. According to the scientists, this might suggest to an electrical communication network between cancer cells that could one day be a target for disruption, leading to the creation of possible new therapies.

Dr Amanda Foust, a co-lead author from Imperial’s Department of Bioengineering, said: “When healthy cells develop into cancerous cells, the changes they go through can aid in their growth and dissemination. For instance, we are aware that certain genes that regulate cell multiplication can become inactive, leading to unchecked cell growth.”
“We don’t yet know why the voltage of membranes fluctuates in cancer cells – but our discovery and technology, enabled by the exciting collaboration of engineers and biologists, opens doors to further work that could help us better understand cancer signalling networks and growth.”

Despite the fact that leprosy is one of the world’s oldest and most persistent illnesses, the bacteria that causes it may have an unexpected capacity to grow and regenerate a key organ. The findings were reported in Cell Reports Medicine. Scientists have discovered that leprosy parasites may reprogramme cells in adult animals to increase the size of the liver without causing damage, scarring, or tumours. The findings imply that humans may use this natural mechanism to repair ageing livers and enhance healthspan (the amount of time they live disease-free).

According to experts, it may also aid in the regeneration of damaged livers, lowering the need for transplantation, which is presently the only curative option for those with end-stage scarred livers. Previous research boosted mouse liver recovery by creating stem cells and progenitor cells (the step following a stem cell that may become any type of cell for a given organ) using an invasive procedure that frequently resulted in scarring and tumour formation. To combat these negative side effects, Edinburgh researchers based on their prior discoveries of Mycobacterium leprae’s partial cellular reprogramming potential.

Working with the US Department of Health and Human Services in Baton Rouge, Louisiana, the researchers infected 57 armadillos with the parasite and compared their livers to those of uninfected armadillos and those determined to be resistant to infection. They discovered that infected animals grew bigger – but healthy and uninjured – livers with the same critical components as uninfected and resistant armadillos, such as blood arteries, bile ducts, and functional units known as lobules. The researchers believe the bacteria ‘hijacked’ the liver’s natural regeneration capacity to expand the organ’s size and so give it with additional cells to grow in.

They also uncovered multiple signs that the primary types of liver cells, known as hepatocytes, had “rejuvenated” in the sick armadillos. The diseased armadillos’ livers also had gene expression patterns – the blueprint for constructing a cell – that were identical to those found in younger animals and human embryonic livers.

Genes associated with metabolism, growth, and cell proliferation were activated, whereas genes associated with ageing were downregulated or inhibited. Scientists believe this is because the bacteria reprogrammed the liver cells, restoring them to an earlier stage of progenitor cells, from which new hepatocytes and liver tissues developed. The researchers believe their findings will contribute in the development of human medicines for ageing and damaged livers. Every year, liver diseases kill two million individuals globally.

Stroke is a major cause of dementia, significant long-term damage, and death. According to the American Heart Association, stroke patients are more likely to develop depression, which has a negative impact on functional and cognitive recovery.

The Texas A&M researchers looked at whether transplanting intestinal epithelial stem cells (IESCs) from healthy donors may restore the intestinal barrier after stroke and enhance outcomes. According to the findings of their preclinical investigation, published in the journal Brain, Behavior, and Immunity, IESC transplantation reduced stroke-induced mortality, reduced the amount of dead tissue and gut leakiness, and averted stroke-induced cognitive impairment.

The only recombinant tissue plasminogen activator approved by the FDA for stroke therapy has a limited track record and must be taken shortly after the beginning of the stroke. Texas A&M University School of Medicine researchers are spearheading research into the association between stroke-induced intestinal permeability, or leakiness, and cognitive impairment, with the objective of improving stroke outcomes.

According to recent research, two-thirds of stroke patients will develop cognitive impairment, and one-third of all stroke patients will develop dementia, so there is a critical need for more effective stroke therapies that preserve cognitive function after acute stroke and remain protective in the weeks following.

Although most stroke therapy research is focused on the brain, the gut responds to stroke quickly and with alterations that may predict many of the inflammatory processes associated with stroke-induced illness. These alterations in the gut, such as increased permeability, are likely to result in the transfer of products generated in the gut into the bloodstream. Many of these products are hazardous, posing a risk of increasing inflammation and exacerbating stroke-induced brain damage.

IESCs heal the gut and decrease permeability, according to evidence from a range of research. These healing pathways may be crucial in retaining cognitive function after a stroke.

“It is clear that the gut-brain axis is involved in injury following stroke,” said Farida Sohrabji, PhD, Regents Professor, department head for Neuroscience and Experimental Therapeutics and senior author of the study. “Factoring in the effects of gut health on the brain following stroke may allow us to more effectively advance stroke therapies.”

In a preclinical model, Sohrabji and her colleagues implanted primary IESCs from healthy donors following stroke.

IESCs derived from young donors restored gut architecture and lowered gut permeability, lowering blood levels of proteins and other chemicals harmful to brain cells. In the weeks following the stroke, IESC transplantation also reduced depressive-like behaviours and cognitive impairment. IESC transplantation from older donors did not enhance stroke outcomes, demonstrating that donor age influences transplant success.

This research, which is still in the preclinical stage, emphasises the necessity of early treatment intervention after stroke and will influence future directions of the work. “Future trials will look towards refining the protocol’s dose and timing,” Sohrabji added. “A comprehensive study of ageing stem cells might also be useful in explaining why older people have more severe strokes.”

Sohrabji, a neurologist who has made major contributions to the literature on stroke causation, revealed that Kathiresh Kumar Mani, PhD, an associate research scientist in her lab, directed this preclinical work. The American Heart Association provided a postdoctoral grant to Mani, who is versed in gut biology, to assist this investigation.

Their combined knowledge has enabled them to take stroke treatment research into new area, with promising outcomes. They also won a large grant from the WoodNext Foundation, which is assisting them with their unique research.

“Ultimately, this research is expected to advance development of novel therapies that target and repair the intestinal epithelium to help mitigate stroke disability,” Sohrabji said, “but the premise–that gut stem cells might be therapeutically valuable outside of the gut–could be considered for a much greater variety of neurological diseases.”

Survivors of abuse and trauma are considerably more likely than other individuals to develop alcohol use disorder (AUD); according to some estimates, up to three-quarters of persons with PTSD have drinking problems. Scripps Researchers have identified a class of drugs that may be capable of breaking this link. The medicine decreased alcohol craving and consumption in PTSD animal models, as well as other PTSD-related features including aggressiveness, excessive fear, and hyperarousal. The findings were reported in the journal Neuropsychopharmacology.

“The overlap of PTSD and AUD is a major problem,” says co-senior author Marisa Roberto, PhD, the Schimmel Family Chair of Molecular Medicine and a professor of Neuroscience at Scripps Research. “We’ve shown that there is potential to alleviate both disorders by targeting brain pathways that they share.”

According to the United States Department of Veterans Affairs’ National Center for PTSD, roughly 12 million individuals in the United States suffer with PTSD in any given year. Men and women with PTSD are more than twice as likely as the general population to misuse or become dependent on alcohol at some time in their life. Furthermore, those with both PTSD and AUD are more likely to have suicidal thoughts and engage in excessive violence than people with just one of the diseases.

According to studies, FKBP5, a protein located in the brain, has been related to both disorders. The FKBP5 gene regulates the brain’s stress response pathways, and genetic variations of the gene have been associated to an increased risk of AUD and PTSD. Higher levels of FKBP5 in animals have been linked to both stress and alcohol exposure. Bryan Cruz, PhD, and Valentina Vozella, PhD, co-first authors, investigated rats displaying symptoms comparable to comorbid human PTSD and AUD. The animals, like people with the disorders, drink more alcohol than the average person, are angry and fearful, and have anxiety and sleep problems, the researchers observed.

The rats were given either benztropine (Cogentin), an FDA-approved Parkinson’s disease treatment that targets many molecules in the brain, or SAFit2, an investigational chemical developed specifically to disrupt FKBP5.

They discovered that benztropine decreased alcohol desire and aggressive behaviour in stressed male and female animals. SAFit2 reduced alcohol consumption in stressed males and lowered intense fear in both males and females. Neither medicine interfered with sleep.

“The results may have varied between male and female animals because of reproductive hormones,” says Cruz. “There is new literature suggesting that the activity of these kinds of compounds varies in females throughout the oestrous cycle.”

According to the researchers, the fact that benztropine is currently FDA-approved shows the possibility of repurposing it in persons suffering from PTSD.

“We think FKBP5 inhibitors might be useful in preventing AUD after the onset of PTSD,” adds co-senior author Eric Zorrilla, PhD, associate professor in the Department of Molecular Medicine. “More work is needed to determine whether these compounds also can prevent the recurrent relapse that hampers recovery.”

According to recent study, children who have experienced deprivation are more prone than those who have not to make hasty decisions, which can lead to addictions later in life. ‘Trait impulsivity,’ or the need for instant satisfaction, has been related to increased expenditure on food, particularly unhealthy, high-calorie foods. According to studies, children who suffer poverty and food insecurity as youngsters have a higher BMI as adults than those who do not. Researchers at Aston University’s School of Psychology discovered a link between childhood deprivation and impulsive behaviour, which can lead to addiction later in life.

The findings, the result of six years of research, also discovered a new relationship between impulsivity, obesity, and the cost of living issue. Professor Richard Tunney, chair of Aston University’s School of Psychology, released a research in Scientific Reports earlier this year showing that children who suffer deprivation make more impulsive choices than children who do not. The study contrasted 146 children, with an average age of eight, living in some of England’s most destitute districts to youngsters living in some of the most affluent neighbourhoods. Children were offered the option of taking home a modest sum of money (for example, GBP1) or receiving GBP10 every week, or even more after a year.

The length of time a person is prepared to wait for a bigger sum of money may be used to compute a ‘discount rate,’ which illustrates how much the waiting time affects the value of the money. An impulsive individual may choose GBP1 today since the value of GBP10 in six months has been ‘discounted’ to less than GBP1. This implies that the GBP10 is reduced by GBP9 throughout the six-month wait for them. A less impulsive individual could be ready to wait six months for GBP10 but not a year for GBP15. This means that the value of the GBP15 is reduced by GBP5 due to the additional six-month delay. This discount rate is a measure of someone’s impulsiveness.

Commenting on the findings, Professor Tunney said: “The results showed that children living in the most deprived areas had significantly higher discount rates than children living in the least deprived areas, regardless of age or intelligence, indicating that deprivation was the causal factor in the children’s choice. “This preference for immediate outcomes is a stable personality trait that remains constant throughout a person’s life.”

However, in the most recent study published by the Royal Society, the research team evaluated impulsivity in over 1,000 older persons aged 50 to 90. The study discovered that older persons living in the most destitute regions preferred smaller-sooner financial rewards, much as the children in the first study. It was also discovered that a person’s work indicated the decisions they made. Adults working in technical or regular activities, such as mechanics or cleaners, preferred to get lesser sums of money rather than wait for greater sums, when compared to persons working in professional occupations, such as engineers or scientists.

Professor Tunney added: “These findings are concerning because impulsivity doesn’t just predict obesity. These findings tell us a lot about why people living in poorer areas tend to be unhealthier than people living in wealthy areas.”
“People who experience deprivation as children are more likely to choose to do things that, although they might be pleasurable in the short term, are unhealthy in the long run. This includes overeating, taking drugs, smoking cigarettes and gambling. “We know too, that impulsivity can help to explain why some people go on to become addicts, while other people can avoid some of the more harmful effects of drugs and alcohol.”

“Deprivation is one of many factors that can lead to impulsive behaviour throughout a person’s lifetime. Genetics also plays a role in impulsivity. Policymakers can’t do anything about a person’s genes but they can influence the nation’s long-term mental and physical health by minimising child poverty. Failing to do so will have long-term implications for the children living through today’s cost of living crisis.”

Researchers uncovered five genetic variants that enhance the likelihood of becoming nearsighted as children grow older. These findings were published in the open-access journal PLOS Genetics by a team lead by Jeremy Guggenheim of Cardiff University in the United Kingdom. Nearsightedness is linked to a variety of eye problems, making it a primary cause of permanent visual impairment in the elderly. People frequently acquire nearsighted as children, and the disease appears to be caused by a combination of genetics, little outdoor time, and many years of education.

More than 450 genetic variations have been linked to an elevated risk of nearsightedness in studies, although few have been proved to raise risk particularly in those with the related lifestyle variables. Researchers examined genetic and health data from over 340,000 European ancestors in the new study. In conjunction with intense schooling, they conducted a genome-wide investigation to find genetic variations that make people more prone to being nearsighted. The study discovered five genetic variations that raised an individual’s likelihood of becoming nearsighted as they spent more time in school – notably for persons with a degree education.

Three of these variations were previously identified, while the other two were discovered in investigations of East Asian cohorts, where around 80% of children develop nearsightedness. In the West, around 30% of children acquire nearsightedness. These findings, according to the researchers, reveal fresh insights into the molecular mechanisms that produce nearsightedness, but further study is needed to understand how those pathways combine with lifestyle variables to generate the illness.

Guggenheim adds, “As well as requiring the need for glasses or contact lenses, myopia is a leading cause of uncorrectable visual impairment. Building on our previous research linking education and myopia, the new study identifies 5 genes associated with myopia development whose effects are amplified by additional years spent in education.”

The protein medin, like the protein amyloid-, accumulates in the blood vessels of Alzheimer’s patients’ brains. DZNE researchers discovered this ‘co-aggregation.’ Their discovery has subsequently been published in the prestigious journal Nature.

“Although Medin has been around for more than 20 years, its impact on illnesses was previously underrated. We were able to demonstrate that medin considerably increases the pathological changes in the blood vessels of Alzheimer’s patients “explains Dr Jonas Neher, the study’s principal investigator and director of the DZNE’s Tubingen location.

The University of Tubingen, the Hertie Institute for Clinical Brain Research in Tubingen, and a variety of international organisations and cooperation partners all contributed to this extensive study. Amyloid is exemplified by Medin. The most well-known of these proteins is amyloid-, which clumps in the brains of Alzheimer’s patients. The brain’s blood arteries and tissue are both injured as a result of these aggregates’ eventual deposition as plaques, which in turn destroy the brain’s nerve cells and blood vessels.

But while amyloid- has been the subject of numerous investigations, medin has not drawn much attention. Jonas Neher notes that “there was minimal evidence of pathology, that is, of a clinically noteworthy finding connected with medin,” and that “pathology is frequently the prerequisite for a more in-depth research of an amyloid.”

Medin, on the other hand, is the most common amyloid and may be found in the blood vessels of nearly everyone over the age of 50. Jonas Neher and his colleagues discovered that medin appears in old mice and published their findings in the scientific journal PNAS two years ago.
It was revealed at the time that medin accumulated more in the mice’s brain blood vessels as they matured.

Furthermore, as the brain becomes active and blood flow increases, medin-deposited blood vessels expand more slowly than medin-free blood vessels. However, the capacity of blood vessels to develop is critical for providing the brain with adequate oxygen and nutrients.

On top of that, the researchers’ most recent studies focused on Alzheimer’s disease. First, scientists were able to show in Alzheimer’s mouse models that the presence of amyloid deposits leads medin to accumulate substantially more strongly in the blood arteries of the brain.

Importantly, the study of brain tissue from organ donors with Alzheimer’s disease validated these findings. However, far fewer amyloid- deposits accumulated in mice whose genes were changed to prevent the production of medin, resulting in fewer blood vessel damage.

“There are only a handful of research groups worldwide working on medin at all,” says Jonas Neher. A recent study from the United States found that medin levels may rise in Alzheimer’s sufferers. However, it was unclear if this rise was simply a result of the sickness or if it was one of the reasons.

“We have now been able to show through many experiments that medin actually promotes vascular pathology in Alzheimer’s models,” Neher said. So medin deposits are indeed a cause of blood vessel damage. “And this indicates that medin is one of the causes of the disease,” Neher said.

The scientists employed tissue pieces from mice and Alzheimer’s patients that had been coloured so that certain proteins could be detected in their study. They were able to show that medin and amyloid- are co-localized, or deposited together, in the blood vessels of the brain. They were able to show that these two amyloids co-aggregate, or form mixed deposits, in a later stage.

According to Jonas Neher, the findings “amazingly, medin interacts directly with amyloid- and enhances its aggregation – which was entirely unknown.” This realisation has given the researchers hope for the development of a revolutionary therapy.

As a result of amyloid buildup in the brain’s blood vessels, they suggest that Medin “may be a therapeutic target to avoid vascular injury and cognitive decline.”

Alzheimer’s disease is undoubtedly facilitated by vascular alterations, impaired function, or damage to blood vessels, as well as amyloid-aggregates in brain tissue. Patients may benefit from medicines that target both damaged blood vessels and plaques.

The next phase will be to see if medin aggregates can be eliminated therapeutically and, if so, whether this intervention ha any effect on cognitive performance. The researchers intend to test this in mice initially since animal models properly replicate the pathogenic changes in Alzheimer’s sufferers.